Literature DB >> 12766915

The early stage of vascular dementia: significance of a complete therapeutic program.

L S Kruglov1.   

Abstract

THEORY: Mild manifestations of vascular dementia are relatively widespread among the old-age population. Drug therapy for this disorder is insufficiently effective at present, making it necessary to improve the treatment of such patients by means of an adequate psychotherapeutic and rehabilitation program. AIMS: To assess the role of psychotherapeutic and rehabilitation measures in improving outcome in the early stage of vascular dementia.
METHODS: The test and control cohorts (each n = 95) were matched for characteristics found to be significant for outcome of treatment (the relevant predictors were found using Multiple Regression Analysis). The cohorts differed in the amount of the psychotherapy and rehabilitation received. To assess the effects of treatment the SCAG scale and a special scale for evaluating the level of activity in the household were used.
RESULTS: In the test cohort the patients' condition improved significantly compared with the controls. Even in case of only slight therapeutic reduction of psychopathologic symptoms the systematic use of psychotherapeutic and rehabilitation methods favoured preserving a certain level of activity in the household and for some patients even improving it.
CONCLUSIONS: The results of therapy at the early stage of vascular dementia to a great extent depend on carrying out a full-scale psychotherapeutic and rehabilitation program. The positive significance of the latter is connected not only with improvement of clinical indices but also with direct optimizing the every day life activity level. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12766915     DOI: 10.1002/gps.844

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  1 in total

1.  [Non-pharmacological treatment of dementia in geriatric psychiatry care units : Scoping review].

Authors:  Anne Göhner; Michael Hüll; Sebastian Voigt-Radloff
Journal:  Z Gerontol Geriatr       Date:  2016-12-16       Impact factor: 1.281

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.